13
Views
1
CrossRef citations to date
0
Altmetric
Research Article

The peroxisome proliferator phenylbutyric acid (PBA) protects astrocytes from ts 1 MoMuLV-induced oxidative cell death

Pages 318-325 | Published online: 10 Jul 2009
 

Abstract

Oxidative stress is involved in the pathogenesis of several neurodegenerative diseases, including Parkinson's disease, Alzheimer's disease, and HIV neuroAIDS. In this study, we have investigated an agent, phenylbutyric acid, that ameliorates cell death in murine astrocytes infected with ts 1 MoMuLV ( ts 1). Phenylbutyric acid, an aromatic short chain fatty acid, was shown to prevent the loss of catalase that occurs in ts 1 infected astrocytes, and to prevent ts 1-mediated cell death. Cell cotransfection studies demonstrated that phenylbutyric acid activates peroxisome proliferator receptors (PPARs) in astrocytes, and binds to the peroxisome proliferator-activated receptors &#102 and &#110 . This observation suggests that the effects of PBA may be mediated by PPARs in astrocytes. Phenylbutyric acid also maintained catalase protein levels in brain of ts 1-infected mice, and delayed the hindlimb paralysis caused by ts 1 infection. Because PBA activates peroxisome proliferator-activated receptors and prevents loss of catalase, we suggest that ts 1-induced oxidative stress in infected astrocytes that is alleviated by PBA is mediated via PPAR &#102 and/or PPAR &#110 . Journal of NeuroVirology (2002) 8, 318-325.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.